Exscientia PLCNASDAQ:EXAI
- LAST PRICE5.3700
- TODAY'S CHANGE (%)0.1500 (2.8736%)
- Bid / Lots5.3200/ 1
- Ask / Lots5.4800/ 1
- Open / Previous Close5.2600 / 5.2200
- Day Range
- 52 Week Range
- Volume316,033
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | EXAI |
|---|---|---|
| 09:32 ET | 20742 | 5.3 |
| 09:36 ET | 337 | 5.2429 |
| 09:38 ET | 1400 | 5.27 |
| 09:39 ET | 100 | 5.275 |
| 09:41 ET | 600 | 5.2758 |
| 09:43 ET | 1838 | 5.27 |
| 09:45 ET | 150 | 5.27 |
| 09:48 ET | 5666 | 5.27 |
| 09:50 ET | 323 | 5.28 |
| 09:52 ET | 500 | 5.27 |
| 09:54 ET | 438 | 5.26 |
| 09:56 ET | 1376 | 5.25 |
| 09:57 ET | 780 | 5.24 |
| 09:59 ET | 1200 | 5.25 |
| 10:01 ET | 2130 | 5.26 |
| 10:03 ET | 4276 | 5.2875 |
| 10:06 ET | 1455 | 5.2899 |
| 10:08 ET | 1636 | 5.27 |
| 10:10 ET | 200 | 5.27 |
| 10:12 ET | 1986 | 5.2858 |
| 10:14 ET | 430 | 5.275 |
| 10:15 ET | 1000 | 5.27 |
| 10:17 ET | 295 | 5.26 |
| 10:19 ET | 2582 | 5.2718 |
| 10:21 ET | 200 | 5.27 |
| 10:24 ET | 100 | 5.27 |
| 10:26 ET | 400 | 5.275 |
| 10:28 ET | 900 | 5.28 |
| 10:30 ET | 500 | 5.28 |
| 10:32 ET | 1563 | 5.26 |
| 10:33 ET | 100 | 5.26 |
| 10:35 ET | 1485 | 5.26 |
| 10:39 ET | 1020 | 5.265 |
| 10:42 ET | 1640 | 5.2818 |
| 10:44 ET | 438 | 5.285 |
| 10:46 ET | 600 | 5.28 |
| 10:48 ET | 200 | 5.285 |
| 10:50 ET | 368 | 5.27 |
| 10:51 ET | 100 | 5.27 |
| 10:53 ET | 114 | 5.27 |
| 10:55 ET | 100 | 5.26 |
| 11:00 ET | 389 | 5.275 |
| 11:06 ET | 1626 | 5.26 |
| 11:09 ET | 242 | 5.27 |
| 11:11 ET | 11298 | 5.295 |
| 11:13 ET | 30486 | 5.3399 |
| 11:15 ET | 100 | 5.31 |
| 11:18 ET | 2253 | 5.29 |
| 11:20 ET | 3000 | 5.29 |
| 11:22 ET | 100 | 5.26 |
| 11:24 ET | 300 | 5.26 |
| 11:26 ET | 600 | 5.28 |
| 11:27 ET | 850 | 5.26 |
| 11:29 ET | 6509 | 5.28 |
| 11:31 ET | 200 | 5.28 |
| 11:33 ET | 244 | 5.28 |
| 11:36 ET | 625 | 5.3 |
| 11:38 ET | 574 | 5.28 |
| 11:40 ET | 500 | 5.31 |
| 11:42 ET | 425 | 5.325 |
| 11:44 ET | 327 | 5.3321 |
| 11:45 ET | 1740 | 5.34 |
| 11:47 ET | 2675 | 5.34 |
| 11:51 ET | 1361 | 5.355 |
| 11:54 ET | 187 | 5.368 |
| 11:56 ET | 5170 | 5.35 |
| 11:58 ET | 347 | 5.36 |
| 12:00 ET | 385 | 5.37 |
| 12:02 ET | 200 | 5.36 |
| 12:03 ET | 200 | 5.37 |
| 12:05 ET | 448 | 5.372 |
| 12:07 ET | 1757 | 5.39 |
| 12:12 ET | 3292 | 5.42 |
| 12:14 ET | 100 | 5.405 |
| 12:16 ET | 650 | 5.4 |
| 12:18 ET | 1449 | 5.39 |
| 12:20 ET | 2200 | 5.3901 |
| 12:21 ET | 185 | 5.3975 |
| 12:23 ET | 573 | 5.38 |
| 12:25 ET | 200 | 5.3888 |
| 12:27 ET | 1036 | 5.39 |
| 12:30 ET | 935 | 5.41 |
| 12:32 ET | 234 | 5.38 |
| 12:36 ET | 920 | 5.37 |
| 12:39 ET | 1500 | 5.38 |
| 12:41 ET | 750 | 5.3907 |
| 12:43 ET | 800 | 5.39 |
| 12:45 ET | 1100 | 5.39 |
| 12:50 ET | 2217 | 5.4 |
| 12:56 ET | 2940 | 5.415 |
| 12:59 ET | 1700 | 5.4 |
| 01:01 ET | 100 | 5.4 |
| 01:03 ET | 2440 | 5.38 |
| 01:06 ET | 100 | 5.37 |
| 01:08 ET | 141 | 5.37 |
| 01:10 ET | 512 | 5.36 |
| 01:12 ET | 2768 | 5.35 |
| 01:14 ET | 100 | 5.36 |
| 01:15 ET | 200 | 5.35 |
| 01:17 ET | 1800 | 5.35 |
| 01:19 ET | 2200 | 5.35 |
| 01:24 ET | 300 | 5.34 |
| 01:26 ET | 250 | 5.352 |
| 01:30 ET | 300 | 5.35 |
| 01:33 ET | 100 | 5.35 |
| 01:35 ET | 1719 | 5.33 |
| 01:37 ET | 1450 | 5.3395 |
| 01:39 ET | 11027 | 5.31 |
| 01:42 ET | 400 | 5.32 |
| 01:44 ET | 100 | 5.31 |
| 01:46 ET | 1801 | 5.32 |
| 01:48 ET | 395 | 5.33 |
| 01:50 ET | 459 | 5.321 |
| 01:51 ET | 100 | 5.3315 |
| 01:53 ET | 100 | 5.33 |
| 01:55 ET | 100 | 5.3309 |
| 01:57 ET | 996 | 5.33 |
| 02:00 ET | 448 | 5.32 |
| 02:04 ET | 100 | 5.32 |
| 02:06 ET | 1162 | 5.315 |
| 02:08 ET | 106 | 5.31 |
| 02:09 ET | 1965 | 5.32 |
| 02:13 ET | 2404 | 5.31 |
| 02:18 ET | 2724 | 5.32 |
| 02:24 ET | 2406 | 5.32 |
| 02:27 ET | 500 | 5.32 |
| 02:31 ET | 4460 | 5.31 |
| 02:33 ET | 900 | 5.31 |
| 02:36 ET | 100 | 5.31 |
| 02:38 ET | 800 | 5.31 |
| 02:42 ET | 2045 | 5.31 |
| 02:45 ET | 800 | 5.31 |
| 02:47 ET | 5581 | 5.31 |
| 02:49 ET | 944 | 5.325 |
| 02:54 ET | 870 | 5.335 |
| 02:56 ET | 186 | 5.335 |
| 02:58 ET | 128 | 5.33 |
| 03:02 ET | 1000 | 5.34 |
| 03:03 ET | 1363 | 5.33 |
| 03:07 ET | 1895 | 5.31 |
| 03:09 ET | 900 | 5.3106 |
| 03:12 ET | 100 | 5.32 |
| 03:14 ET | 1995 | 5.31 |
| 03:16 ET | 100 | 5.3 |
| 03:18 ET | 200 | 5.31 |
| 03:20 ET | 600 | 5.33 |
| 03:21 ET | 159 | 5.31 |
| 03:23 ET | 288 | 5.32 |
| 03:25 ET | 2391 | 5.33 |
| 03:27 ET | 2546 | 5.355 |
| 03:32 ET | 386 | 5.355 |
| 03:34 ET | 1711 | 5.355 |
| 03:36 ET | 100 | 5.35 |
| 03:38 ET | 2468 | 5.35 |
| 03:39 ET | 400 | 5.345 |
| 03:41 ET | 2744 | 5.3582 |
| 03:43 ET | 300 | 5.355 |
| 03:45 ET | 200 | 5.355 |
| 03:48 ET | 2461 | 5.345 |
| 03:50 ET | 613 | 5.34 |
| 03:52 ET | 2146 | 5.35 |
| 03:54 ET | 385 | 5.35 |
| 03:56 ET | 2202 | 5.335 |
| 03:57 ET | 4040 | 5.35 |
| 03:59 ET | 3248 | 5.37 |
Jul 18, 2024
DJ Exscientia Shares Down On Unchanged Cash Runway Expectations After Acquisition, from 1:21PM ET on Thursday Jul 18, 2024 by Dow Jones
1:21PM ET on Thursday Jul 18, 2024 by Dow JonesExscientia Acquires Full Rights to Potential Best-in-Class CDK7 Inhibitor Ahead of Phase 1 Dose Escalation Data Readout, from 7:00AM ET on Thursday Jul 18, 2024 by Dow Jones
7:00AM ET on Thursday Jul 18, 2024 by Dow Jones
Jul 10, 2024
Exscientia Launches AWS AI-powered Platform to Advance Drug Discovery, from 7:00AM ET on Wednesday Jul 10, 2024 by Dow Jones
7:00AM ET on Wednesday Jul 10, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Exscientia PLC | 452.7M | -4.1x | --- |
OmniAb Inc | 564.6M | -7.6x | --- |
Contineum Therapeutics Inc | 541.5M | 27.6x | --- |
Iteos Therapeutics Inc | 603.6M | -4.6x | --- |
Applied Therapeutics Inc | 594.2M | -2.7x | --- |
Verve Therapeutics Inc | 628.1M | -2.6x | --- |
Company Information
Exscientia PLC is a drug design and development company. The Company combines precision design with integrated experimentation to invent and develop drugs. It uses artificial intelligence (AI) in drug discovery to progress AI-designed small molecules into a clinical setting. It uses the patient's tissue data to define optimal profiles for research, improve experimental assessment during design and improve outcomes in a medical setting. It has developed an internal pipeline focused on oncology, while its partnered pipeline extends to various other therapeutic areas. It combines genetic data and global literature in machine learning models to anticipate and confirm disease-target associations. The Company's experimental platform records responses in real patient samples allowing it to generate high-precision views of potential patient response. Its product pipeline consists of GTAEXS617, EXS4318, EXS74539, and EXS73565.
Contact Information
- Headquarters
- The Schrodinger Building Oxford Science ParkOXFORD, United Kingdom OX4 4GE
- Phone
- 186-581-8941
- Fax
- ---
Executives
- Non-Executive Independent Chairman of the Board
- Elizabeth Crain
- Chief Executive Officer, Director
- David Hallett
- Chief Financial and Strategy Officer, Director
- Ben Taylor
- Chief Technology Officer
- John Overington
- Interim Chief Medical Officer
- Maria-louise Fjaellskog
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $452.7M |
|---|---|
Revenue (TTM) | $25.2M |
Shares Outstanding | 86.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.31 |
Book Value | $3.64 |
P/E Ratio | -4.1x |
Price/Sales (TTM) | 18.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -802.76% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
